-
Advanced Therapies and the Unmet Need in Systemic Lupus Erythematosus Patients: Results From a Real-World Study in the United States and Germany
Sep 9, 2025, 16:22 PM -
Staying Competitive in a Crowded Vaccine Market: Is There Room for a Third or Fourth Entrant in the Same Disease Area?
Sep 9, 2025, 16:22 PM -
Improving Time to Patient: Insights From the Canadian Cancer Treatment Hackathons
Sep 9, 2025, 16:22 PM -
An AI-Enhanced Targeted Literature Review Workflow to Support Inclusive Research Practices and Population Science Research: A Human-in-the-Loop Approach
Sep 9, 2025, 16:22 PM -
A Health Economic Evaluation Framework for Implementing a Digital Survivorship Passport for Childhood Cancer Survivors
Sep 9, 2025, 16:22 PM -
Adapting to Change: Analysis of Trend Estimation in AMNOG Dossiers Under Revised GBA Guidelines
Sep 9, 2025, 16:22 PM -
Patient-Centered Hearing Technology Assessment: Integrating ICF Into Multicriteria Decision Making
Sep 9, 2025, 16:22 PM -
Analysis and Characterization of Variations in Conceptual and Operational Definitions for GLP-1 Agonist Treatment Eligibility for Weight Management
Sep 9, 2025, 16:22 PM -
Variations in Screening and Medication Takeup Rates for Alzheimer’s Disease
Sep 9, 2025, 16:22 PM -
Real-World Evidence in Action: Assessing Drug-Drug Interactions to Drive Value-Based Decisions
Sep 9, 2025, 16:22 PM -
The Rise of Optimization in NICE Guidance: A Two-Decade Review With a Focus on Prevention
Sep 9, 2025, 16:22 PM -
Foregone Net Monetary Benefit From Underdiagnosis and Undertreatment of Mild Cognitive Impairment Due to Alzheimer’s Disease in the Medicare Population
Sep 9, 2025, 16:22 PM -
Factors Associated With the Publication of Real-World Evidence Studies in Lung Cancer by Journal Impact Factor
Sep 9, 2025, 16:22 PM -
Mapping Access Pathways for New Medicines in Finland: A Real-World Review of HTA and Reimbursement Decisions
Sep 9, 2025, 16:22 PM -
Patient Perspectives on Mild-Moderate Infection Burden in Multiple Myeloma and Chronic Lymphocytic/Small Lymphocytic Leukemia
Sep 9, 2025, 16:22 PM -
A Budget Impact Analysis of Switching From Von Willebrand Factor/Factor VIII Plasma-Derived Concentrate With 2.4-1 Ratio to the Concentrate With 1-1 Ratio for the Management of Von Willebrand Disease in Qatar
Sep 9, 2025, 16:22 PM -
Costs Associated With Kidney Transplant in Portugal
Sep 9, 2025, 16:22 PM -
Cost-Utility of Intramuscular Testosterone for Men and Male Adolescents With Organic Hypogonadotropic Hypogonadism in Brazil
Sep 9, 2025, 16:22 PM -
Healthcare Resource Utilization Among Adults With Pneumococcal Disease in England 2017-2022: A Retrospective Database Analysis
Sep 9, 2025, 16:22 PM -
Dihydropyrimidine Dehydrogenase (DPYD) Genetic Testing Before Fluoropyrimidine-Based Adjuvant Chemotherapy for Colorectal Cancer in Qatar: A Cost-Effective Approach
Sep 9, 2025, 16:22 PM
